Article Versions Notes

Zheng X, Liu X, Wang Z, Li R, Zhao Q, Song B, Cheong K-L, Chen J, Zhong S. Selenium–Chondroitin Sulfate Nanoparticles Inhibit Angiogenesis by Regulating the VEGFR2-Mediated PI3K/Akt Pathway. Marine Drugs. 2025; 23(1):22. https://doi.org/10.3390/md23010022

Zheng, Xia, Xiaofei Liu, Zhuo Wang, Rui Li, Qiaoli Zhao, Bingbing Song, Kit-Leong Cheong, Jianping Chen, and Saiyi Zhong. 2025. "Selenium–Chondroitin Sulfate Nanoparticles Inhibit Angiogenesis by Regulating the VEGFR2-Mediated PI3K/Akt Pathway" Marine Drugs 23, no. 1: 22. https://doi.org/10.3390/md23010022

Zheng, X., Liu, X., Wang, Z., Li, R., Zhao, Q., Song, B., Cheong, K.-L., Chen, J., & Zhong, S. (2025). Selenium–Chondroitin Sulfate Nanoparticles Inhibit Angiogenesis by Regulating the VEGFR2-Mediated PI3K/Akt Pathway. Marine Drugs, 23(1), 22. https://doi.org/10.3390/md23010022